Context Therapeutics Inc. (CNTX)

NASDAQ

$0.21

$-0.02

(-9.03%)

Regular Market

Context Therapeutics Inc. (CNTX) Live Price Chart

Last updated: ⁦2026-10-28 19:17:00⁩. Prices reflect the latest regular market data. Stock price data is sourced from Massive.

Summary

Context Therapeutics Inc. (CNTX) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at $0.21, with a market capitalization of $22.04M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $0.21 to $3.62. This page covers its latest market performance, valuation, price trends and company information.

Key Market Data

Market Cap	$22.04M
Open	$0.23
Day's High	$10.87
Day's Low	$0.21
Previous Close	$0.23
Volume	1.05M
Average Volume	1.53M
P/E Ratio	--
52-Week High	$3.62
52-Week Low	$0.21
Dividend Yield	--
Earnings Date	--

Context Therapeutics Inc. (CNTX) Stock Price Today

Context Therapeutics Inc. (CNTX) is currently trading at $0.21 as of 2026-10-28 19:00:34, down 8.82% ($0.02) from the previous close of $0.23

During today's regular trading session, CNTX has traded between $0.21 and $10.87, with a trading volume of 1.05M shares. The current price is near the lower end of today's range.

Context Therapeutics Inc. (CNTX) 7-Day Stock Price Change

Over the past seven days, Context Therapeutics Inc. (CNTX) moved from $0.24 to $0.21, representing a decline of 10.23% ($0.02).

The stock traded between $0.21 and $0.27 during the period. The latest price is near the lower end of the 7-day range, indicating strong downward.

The average daily volume was 1.17 million shares, up versus the previous seven-day period, indicating higher trading activity.

CNTX 52-Week Price Position

Position in Range: 0.0%

52W Low$0.21

52W High$3.62

CNTX is currently trading at $0.21, placing it 0.0% of the way from its 52-week low of $0.21 to its 52-week high of $3.62. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.

What is Context Therapeutics Inc. (CNTX)?

Context Therapeutics Inc is a clinical-stage biopharmaceutical company advancing medicines for solid tumors. The development team is advancing a pipeline of various therapies with a primary focus on treating female, hormone-dependent cancer, including breast, ovarian, and endometrial cancer. The company's preclinical program, CTIM-76, is an anti-Claudin 6 (CLDN6) x anti-CD3 bispecific antibody (bsAb) that is intended to redirect T-cell-mediated lysis toward malignant cells expressing CLDN6.

Context Therapeutics Inc. Information

Industry	PHARMACEUTICAL PREPARATIONS
Employees	15
Exchange	NASDAQ
Company Website	https://www.contexttherapeutics.com

How to Buy Context Therapeutics Inc. (CNTX) Stock on MEXC

Eligible investors can buy real shares of Context Therapeutics Inc. (CNTX) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.

Step 1: Open and Verify Your RealStocks Account

Log in to the MEXC App, go to Trade → RealStocks, and select Open Account. Complete the required account-opening and identity verification process with MEXC's partner licensed broker.

Step 2: Transfer USDT to Your RealStocks Account

Go to Wallets → RealStocks and transfer USDT from your Spot Account to your RealStocks Account. RealStocks are quoted in USD, while account funding can be completed using USDT.

Step 3: Search for CNTX and Place Your Order

Open the RealStocks trading page and search for CNTX. Select a market or limit order, enter the price and quantity as required, review the order details, and submit your order. Once filled, the corresponding real shares will be held in your RealStocks Account.

Frequently Asked Questions (FAQ)

1.What is Context Therapeutics Inc. (CNTX) stock price today?

Context Therapeutics Inc. (CNTX) is currently trading at $ 0.21, down 8.82% ($0.02) from the previous close of $ 0.23. Intraday prices update in real time during regular trading hours.

2.Is CNTX stock going up or down today?

As of 2026-10-28 19:00:34, CNTX is trading at $ 0.21, down 8.82% ($0.02) from its previous close of $ 0.23. The stock has traded between $ 0.21 and $ 10.87 during today’s regular session. Past price movements do not guarantee future results.

3.What is CNTX pre-market price?

As of 2026-10-28 19:00:34, CNTX is trading at $ 0.24 in pre-market trading, up 0.55% ($0.00) from the previous close of $ 0.23. Pre-market prices reflect trading activity before the regular session opens and may experience lower liquidity and higher volatility.

4.What is CNTX after-hours price?

As of 2026-10-28 19:00:34, CNTX is trading at $ 0.24 in after-hours trading, up 2.68% ($0.01) from the regular-session close of $ 0.23. After-hours prices may differ from the regular session’s opening price due to lower liquidity and wider bid-ask spreads.

5.Is CNTX stock trading now?

CNTX trades on the NASDAQ exchange during regular hours, Monday through Friday, 9:30 AM to 4:00 PM ET, excluding public holidays. Pre-market and after-hours trading are also available through select brokers outside these hours.

6.Where does CNTX sit relative to its 52-week high and low?

Over the past 52 weeks, CNTX has traded between a low of $ 0.21 and a high of $ 3.62. At $ 0.21, the stock is positioned 0.0% of the way from its 52-week low to its 52-week high, providing context for its current price within the one-year trading range.

7.What sector is Context Therapeutics Inc. in?

Context Therapeutics Inc. (CNTX) operates in the PHARMACEUTICAL PREPARATIONS sector. Sector classification helps investors compare it with companies exposed to similar market trends and competitive conditions.

8.What is Context Therapeutics Inc.'s market capitalization and where is it listed?

Context Therapeutics Inc. is listed on the NASDAQ exchange with a market capitalization of $ 22.04M. Market cap reflects the total market value of all outstanding shares and is commonly used to classify stocks by size.

9.How is CNTX valued in terms of P/E ratio and EPS?

CNTX trades at a P/E ratio of --, based on trailing-twelve-month EPS of $ -0.50. P/E ratio compares the stock price to earnings per share and is a common starting point for assessing valuation relative to peers.

10.Does Context Therapeutics Inc. pay a dividend?

Context Therapeutics Inc. pays an indicated annual cash dividend of $ 0.00 per share, with a current dividend yield of 0.00% based on the latest share price. Dividend policies are subject to change at the board's discretion.